1. Home
  2. RIVN vs RDY Comparison

RIVN vs RDY Comparison

Compare RIVN & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rivian Automotive Inc.

RIVN

Rivian Automotive Inc.

HOLD

Current Price

$21.11

Market Cap

19.8B

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$14.09

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RIVN
RDY
Founded
2009
1984
Country
United States
India
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.8B
11.6B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
RIVN
RDY
Price
$21.11
$14.09
Analyst Decision
Hold
Strong Buy
Analyst Count
22
1
Target Price
$15.90
$16.90
AVG Volume (30 Days)
47.7M
1.1M
Earning Date
11-04-2025
01-22-2026
Dividend Yield
N/A
0.51%
EPS Growth
N/A
9.95
EPS
N/A
0.79
Revenue
$5,835,000,000.00
$3,851,623,984.00
Revenue This Year
$9.72
$6.12
Revenue Next Year
$30.31
$2.58
P/E Ratio
N/A
$17.78
Revenue Growth
28.21
14.10
52 Week Low
$10.36
$12.26
52 Week High
$22.69
$16.17

Technical Indicators

Market Signals
Indicator
RIVN
RDY
Relative Strength Index (RSI) 65.77 52.19
Support Level $20.69 $13.90
Resistance Level $22.69 $14.32
Average True Range (ATR) 1.26 0.17
MACD 0.31 0.02
Stochastic Oscillator 77.30 66.18

Price Performance

Historical Comparison
RIVN
RDY

About RIVN Rivian Automotive Inc.

Rivian Automotive Inc is an automotive manufacturer that develops and builds electric vehicles ("EVs") as well as software and services. It launches its consumer vehicle business with the R1 platform consisting of two vehicles: the R1T, and the R1S. The company has two reportable segments: Automotive, which derives the majority of revenue, and Software and Services segment. The Automotive reportable segment derives its revenues and cost of revenues from the production and sale of new EVs and the sale of regulatory credits generated by the production and sale of EVs. The Software and services reportable segment derives its revenues and cost of revenues from remarketing, vehicle repair and maintenance services, and vehicle electrical architecture and software development services.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: